Cargando…

Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study

BACKGROUND: Despite high rates of depression and anxiety, little is known about the use of antidepressants amongst individuals diagnosed with inflammatory bowel disease (IBD). AIMS: To evaluate temporal trends in the use of antidepressants; rates of antidepressant initiation and adherence of antidep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayasooriya, Nishani, Blackwell, Jonathan, Saxena, Sonia, Bottle, Alex, Petersen, Irene, Creese, Hanna, Hotopf, Matthew, Pollok, Richard C. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Antidepressant Use in IBD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311162/ https://www.ncbi.nlm.nih.gov/pubmed/35244961 http://dx.doi.org/10.1111/apt.16820

Ejemplares similares

Adherence to 5-aminosalicylic acid maintenance treatment in young people with ulcerative colitis: a retrospective cohort study in primary care
por: Jayasooriya, Nishani, et al.
Publicado: (2023)

Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study
por: Blackwell, Jonathan, et al.
Publicado: (2021)

Combining antidepressants
por: DUNNER, David L
Publicado: (2014)

Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy
por: SAAH, Tammy, et al.
Publicado: (2014)

When is antidepressant polypharmacy appropriate in the treatment of depression?
por: SI, Tianmei, et al.
Publicado: (2014)

Evaluation of antidepressant polypharmacy and other interventions for treatment-resistant depression
por: PENG, Daihui, et al.
Publicado: (2014)

The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population‐based, longitudinal study
por: Burgess, Christopher J., et al.
Publicado: (2022)

Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease
por: Han, Lichy, et al.
Publicado: (2018)

A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease
por: Piester, Travis, et al.
Publicado: (2018)

Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study
por: Rønnow Sand, Jakob, et al.
Publicado: (2022)

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease
por: Anderson, Alyce, et al.
Publicado: (2018)

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study
por: Eriksson, Carl, et al.
Publicado: (2018)

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
por: Ghosh, Subrata, et al.
Publicado: (2017)

Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
por: Darlington, Kimberly, et al.
Publicado: (2023)

Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
por: Lam, Angela Y., et al.
Publicado: (2020)

Minor impact on fertility in men with inflammatory bowel disease: A National Cohort Study from Sweden
por: Druvefors, Emma, et al.
Publicado: (2022)

Paternal use of medications for inflammatory bowel disease and the risk of hospital‐diagnosed infections in the offspring: a nationwide cohort study
por: Friedman, Sonia, et al.
Publicado: (2022)

The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey
por: Madsen, Gorm Roager, et al.
Publicado: (2022)

Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix
por: Atia, Ohad, et al.
Publicado: (2022)

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
por: Kennedy, N A, et al.
Publicado: (2014)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of UK IBD units and patients
por: Hawthorne, A. Barney, et al.
Publicado: (2022)

Emerging Therapeutics Based on the Amino Acid Neurotransmitter System: An Update on the Pharmaceutical Pipeline for Mood Disorders
por: Hecking, Julia, et al.
Publicado: (2021)

IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
por: Le, Peter N., et al.
Publicado: (2015)

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
por: Mahadevan, Uma, et al.
Publicado: (2018)

Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
por: Lichtenstein, Gary R, et al.
Publicado: (2018)

What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?
por: Card, Timothy, et al.
Publicado: (2018)

Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient–Physician Visits
por: Rubin, David T., et al.
Publicado: (2017)

The use of, and outcomes for, inflammatory bowel disease services during the Covid‐19 pandemic: a nationwide observational study
por: Deputy, Mohammed, et al.
Publicado: (2022)

Barriers to optimizing inflammatory bowel disease care in the United States
por: Spencer, Elizabeth A., et al.
Publicado: (2023)

Does the suddenness matter? Antidepressant use before and after a spouse dies suddenly or expectedly of stroke
por: Einiö, Elina, et al.
Publicado: (2021)

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
por: Gutin, Liat S., et al.
Publicado: (2020)

Opportunistic Knocks: A Gardener with Ulcerative Colitis and New Pulmonary Nodules
por: Canakis, Andrew, et al.
Publicado: (2023)

Active tuberculosis in inflammatory bowel disease patients: a case–control study
por: Freitas Cardoso de Azevedo, Matheus, et al.
Publicado: (2023)

Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
por: Martins, Camilla de Almeida, et al.
Publicado: (2023)

Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis
por: Prokopič, Michal, et al.
Publicado: (2023)

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method
por: Reinisch, W, et al.
Publicado: (2013)

Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
por: Volkers, Adriaan, et al.
Publicado: (2022)

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype
por: Broekman, M. M. T. J., et al.
Publicado: (2017)

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study
por: Chanchlani, Neil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dr29k0t6mi54jmbd0ac7ev22vc